Nanjing King-Friend Biochemical Pharmaceutical (603707.SH): Rocuronium Bromide Injection Obtains Drug Registration Certificate.
Jianniu Corporation (603707.SH) announced that the company recently received the approval for Rocuronium Bromide issued by the National Medical Products Administration.
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) announced that the company has recently received the drug registration certificate for Rocuronium Bromide Injection 5ml:50mg and 10ml:100mg issued by the National Medical Products Administration.
Rocuronium Bromide Injection is used as an adjuvant for general anesthesia, to facilitate tracheal intubation during routine induction of anesthesia, and to maintain neuromuscular blockade of skeletal muscles during surgery.
Related Articles
ALLI INTL ED LE (01563) enters into a financing lease agreement for energy-saving equipment for its subsidiary project.
On December 30, Tianli International Holdings (01773) spent HK$228,000 to repurchase 100,000 shares.
Kuang-Chi Technologies (002625.SZ) plans to repurchase company shares worth 50 to 100 million yuan.
ALLI INTL ED LE (01563) enters into a financing lease agreement for energy-saving equipment for its subsidiary project.
On December 30, Tianli International Holdings (01773) spent HK$228,000 to repurchase 100,000 shares.
Kuang-Chi Technologies (002625.SZ) plans to repurchase company shares worth 50 to 100 million yuan.
